Compare Fulford India with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs PIRAMAL ENTERPRISES - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA PIRAMAL ENTERPRISES FULFORD INDIA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 398.8 16.9 2,365.4% View Chart
P/BV x 6.2 1.1 554.9% View Chart
Dividend Yield % 0.1 1.6 5.3%  

Financials

 FULFORD INDIA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
PIRAMAL ENTERPRISES
Mar-19
FULFORD INDIA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs9423,303 28.5%   
Low Rs4501,797 25.0%   
Sales per share (Unadj.) Rs691.4716.5 96.5%  
Earnings per share (Unadj.) Rs11.579.7 14.4%  
Cash flow per share (Unadj.) Rs15.4107.9 14.2%  
Dividends per share (Unadj.) Rs2.0028.00 7.1%  
Dividend yield (eoy) %0.31.1 26.2%  
Book value per share (Unadj.) Rs380.01,477.5 25.7%  
Shares outstanding (eoy) m3.90184.45 2.1%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.03.6 28.3%   
Avg P/E ratio x60.732.0 189.8%  
P/CF ratio (eoy) x45.323.6 191.8%  
Price / Book Value ratio x1.81.7 106.1%  
Dividend payout %17.435.1 49.7%   
Avg Mkt Cap Rs m2,714470,292 0.6%   
No. of employees `0000.47.8 5.7%   
Total wages/salary Rs m50522,504 2.2%   
Avg. sales/employee Rs Th6,073.016,899.4 35.9%   
Avg. wages/employee Rs Th1,137.42,877.7 39.5%   
Avg. net profit/employee Rs Th100.71,879.9 5.4%   
INCOME DATA
Net Sales Rs m2,696132,153 2.0%  
Other income Rs m1253,128 4.0%   
Total revenues Rs m2,822135,281 2.1%   
Gross profit Rs m-4666,290 -0.1%  
Depreciation Rs m155,202 0.3%   
Interest Rs m1044,097 0.0%   
Profit before tax Rs m5420,119 0.3%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m108,611 0.1%   
Profit after tax Rs m4514,701 0.3%  
Gross profit margin %-1.750.2 -3.4%  
Effective tax rate %17.742.8 41.3%   
Net profit margin %1.711.1 14.9%  
BALANCE SHEET DATA
Current assets Rs m1,738122,742 1.4%   
Current liabilities Rs m545310,810 0.2%   
Net working cap to sales %44.3-142.3 -31.1%  
Current ratio x3.20.4 808.1%  
Inventory Days Days4823 210.1%  
Debtors Days Days439 11.1%  
Net fixed assets Rs m12116,904 0.0%   
Share capital Rs m39369 10.6%   
"Free" reserves Rs m1,443272,161 0.5%   
Net worth Rs m1,482272,530 0.5%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m2,077856,261 0.2%  
Interest coverage x6.71.5 461.2%   
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.30.2 841.3%   
Return on assets %2.66.9 38.0%  
Return on equity %3.05.4 55.9%  
Return on capital %4.312.4 34.7%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1715,200 0.1%   
Fx outflow Rs m6734,889 13.8%   
Net fx Rs m-65610,312 -6.4%   
CASH FLOW
From Operations Rs m90-115,975 -0.1%  
From Investments Rs m105-8,265 -1.3%  
From Financial Activity Rs m-14107,525 -0.0%  
Net Cashflow Rs m181-16,650 -1.1%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 4.0 95.0%  
FIIs % 0.1 26.6 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 16.5 128.5%  
Shareholders   4,783 93,274 5.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   GLENMARK PHARMA  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare FULFORD INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling; Sensex Down 235 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY20); Net Profit Up 390.0% (Quarterly Result Update)

Aug 1, 2019 | Updated on Aug 1, 2019

For the quarter ended June 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 4 bn (up 390.0% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS